Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data)

被引：59

作者：

Bavry, AA

Kumbhani, DJ

Helton, TJ

Bhatt, DL

机构：

[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA

[2] Univ Penn, Dept Internal Med, Philadelphia, PA 19104 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2005年 / 95卷 / 12期

关键词：

D O I：

10.1016/j.amjcard.2005.02.015

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We conducted a meta-analysis on 6 studies in 2,963 patients who had coronary artery disease and received a sirolimus-eluting stent or a bare metal stent for revascularization. Compared with bare metal stents, sirolimus-eluting stents did not appear to increase the risk for thrombosis up to 13.5 months after coronary intervention (risk ratio 0.49, 95% confidence interval 0.22 to 1.12, p = 0.09). (c) 2005 by Excerpta Medica Inc.

引用

页码：1469 / 1472

页数：4

共 14 条

[1] Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries - A randomized trial [J].

Ardissino, D ;

Cavallini, C ;

Bramucci, E ;

Indolfi, C ;

Marzocchi, A ;

Manari, A ;

Angeloni, G ;

Carosio, G ;

Bonizzoni, E ;

Colusso, S ;

Repetto, M ;

Merlini, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (22) :2727-2734

[2] A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents [J].

Babapulle, MN ;

Joseph, L ;

Bélisle, P ;

Brophy, JM ;

Eisenberg, MJ .

LANCET, 2004, 364 (9434) :583-591

[3] What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention? A meta-analysis [J].

Bavry, AA ;

Kumbhani, DJ ;

Helton, TJ ;

Bhatt, DL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (06) :941-946

[4] Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting [J].

Bhatt, DL ;

Bertrand, ME ;

Berger, PB ;

L'Allier, PL ;

Moussa, I ;

Moses, JW ;

Dangas, G ;

Taniuchi, M ;

Lasala, JM ;

Holmes, DR ;

Ellis, SG ;

Topol, EJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (01) :9-14

[5]

Cutlip DE, 2001, CIRCULATION, V103, P1967

[6]

*FDA PUBL HLTH NOT, 2003, UPD INF PHYS SUB THR

[7] Drug-eluting stents:: an early systematic review to inform policy [J].

Hill, RA ;

Dündar, Y ;

Bakhai, A ;

Dickson, R ;

Walley, T .

EUROPEAN HEART JOURNAL, 2004, 25 (11) :902-919

[8] Analysis of 1-year clinical outcomes in the SIRIUS trial - A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis [J].

Holmes, DR ;

Leon, MB ;

Moses, JW ;

Popma, JJ ;

Cutlip, D ;

Fitzgerald, PJ ;

Brown, C ;

Fischell, T ;

Wong, SC ;

Midei, M ;

Snead, D ;

Kuntz, RE .

CIRCULATION, 2004, 109 (05) :634-640

[9] Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world" -: The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry [J].

Lemos, PA ;

Serruys, PW ;

van Domburg, RT ;

Saia, F ;

Arampatzis, CA ;

Hoye, A ;

Degertekin, M ;

Tanabe, K ;

Daemen, J ;

Liu, TKK ;

McFadden, E ;

Sianos, G ;

Hofma, SH ;

Smits, PC ;

van der Giessen, WJ ;

de Feyter, PJ .

CIRCULATION, 2004, 109 (02) :190-195

[10] Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy [J].

McFadden, EP ;

Stabile, E ;

Regar, E ;

Cheneau, E ;

Ong, ATL ;

Kinnaird, T ;

Suddath, WO ;

Weissman, NJ ;

Torguson, R ;

Kent, KM ;

Pichard, AD ;

Satler, LF ;

Waksman, R ;

Serruys, PW .

LANCET, 2004, 364 (9444) :1519-1521

← 1 2 →